TA
ABBV icon

TCG Advisors’s AbbVie ABBV Stock Holding History

TCG Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,891
Closed -$284K – 10
2020
Q2 		$284K Buy
+2,891
New +$255K 0.16% 106
2019
Q3 		– Sell
-1,846
Closed -$137K – 121
2019
Q2 		$137K Sell
1,846
-100
-5% -$7.86K 0.13% 105
2019
Q1 		$157K Sell
1,946
-250
-11% -$20.5K 0.14% 96
2018
Q4 		$202K Buy
+2,196
New +$193K 0.2% 75

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

TCG Advisors's ABBV Position: Q3 2020 in Review

TCG Advisors sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 2,891 shares — an estimated $284K sold.

TCG Advisors first reported a position in ABBV in Q4 2018 and held it in 4 quarters. The position peaked at $284K in Q2 2020. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • TCG Advisors reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • TCG Advisors sold 2,891 AbbVie shares in Q3 2020, an estimated $284K.
  • TCG Advisors first reported a position in AbbVie in Q4 2018 and held it in 4 quarters.
  • TCG Advisors's AbbVie position peaked at $284K in Q2 2020.
  • 2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on TCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.